Profico, D.C.; Gelati, M.; Ferrari, D.; Sgaravizzi, G.; Ricciolini, C.; Projetti Pensi, M.; Muzi, G.; Cajola, L.; Copetti, M.; Ciusani, E.;
et al. Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization. Int. J. Mol. Sci. 2022, 23, 13425.
https://doi.org/10.3390/ijms232113425
AMA Style
Profico DC, Gelati M, Ferrari D, Sgaravizzi G, Ricciolini C, Projetti Pensi M, Muzi G, Cajola L, Copetti M, Ciusani E,
et al. Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization. International Journal of Molecular Sciences. 2022; 23(21):13425.
https://doi.org/10.3390/ijms232113425
Chicago/Turabian Style
Profico, Daniela Celeste, Maurizio Gelati, Daniela Ferrari, Giada Sgaravizzi, Claudia Ricciolini, Massimo Projetti Pensi, Gianmarco Muzi, Laura Cajola, Massimiliano Copetti, Emilio Ciusani,
and et al. 2022. "Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization" International Journal of Molecular Sciences 23, no. 21: 13425.
https://doi.org/10.3390/ijms232113425
APA Style
Profico, D. C., Gelati, M., Ferrari, D., Sgaravizzi, G., Ricciolini, C., Projetti Pensi, M., Muzi, G., Cajola, L., Copetti, M., Ciusani, E., Pugliese, R., Gelain, F., & Vescovi, A. L.
(2022). Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization. International Journal of Molecular Sciences, 23(21), 13425.
https://doi.org/10.3390/ijms232113425